Suppr超能文献

以及:感染、免疫调节和疫苗考虑方面的异同。

and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.

机构信息

CIRI - Centre International de Recherche en Infectiologie, Team GIMAP (Saint-Etienne), Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, UJM, Lyon, France.

Boehringer Ingelheim, Global Innovation, Saint-Priest, France.

出版信息

Clin Microbiol Rev. 2023 Sep 21;36(3):e0016422. doi: 10.1128/cmr.00164-22. Epub 2023 Jun 12.

Abstract

and belong to the genus , which comprises 14 other species. is responsible for whooping cough in humans, a severe infection in children and less severe or chronic in adults. These infections are restricted to humans and currently increasing worldwide. is involved in diverse respiratory infections in a wide range of mammals. For instance, the canine infectious respiratory disease complex (CIRDC), characterized by a chronic cough in dogs. At the same time, it is increasingly implicated in human infections, while remaining an important pathogen in the veterinary field. Both can evade and modulate host immune responses to support their persistence, although it is more pronounced in infection. The protective immune responses elicited by both pathogens are comparable, while there are important characteristics in the mechanisms that differ. However, pathogenesis is more difficult to decipher in animal models than those of because of its restriction to humans. Nevertheless, the licensed vaccines for each are different in terms of formulation, route of administration and immune responses induced, with no known cross-reaction between them. Moreover, the target of the mucosal tissues and the induction of long-lasting cellular and humoral responses are required to control and eliminate . In addition, the interaction between both veterinary and human fields are essential for the control of this genus, by preventing the infections in animals and the subsequent zoonotic transmission to humans.

摘要

和属于,其中包含 14 个其他物种。是引起人类百日咳的病原体,在儿童中是一种严重的感染,在成人中则较为轻微或慢性。这些感染仅限于人类,目前在全球范围内呈上升趋势。参与多种哺乳动物的呼吸道感染。例如,犬传染性呼吸道疾病综合征(CIRDC),其特征是狗的慢性咳嗽。同时,它越来越多地与人类感染有关,同时仍然是兽医领域的重要病原体。和都可以逃避和调节宿主的免疫反应,以支持它们的持续存在,尽管在感染中更为明显。两种病原体引起的保护性免疫反应相当,但在机制上存在重要的差异。然而,由于其在人类中的限制,的发病机制比的发病机制更难在动物模型中进行破译。尽管如此,由于配方、给药途径和诱导的免疫反应不同,每种的许可疫苗都有所不同,并且它们之间没有已知的交叉反应。此外,需要针对黏膜组织和诱导持久的细胞和体液反应来控制和消除。此外,兽医和人类领域之间的相互作用对于控制该属至关重要,通过防止动物感染和随后的人畜共患传播到人类。

相似文献

1
and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.
Clin Microbiol Rev. 2023 Sep 21;36(3):e0016422. doi: 10.1128/cmr.00164-22. Epub 2023 Jun 12.
2
Bordetella pertussis transmission.
Pathog Dis. 2015 Nov;73(8):ftv068. doi: 10.1093/femspd/ftv068. Epub 2015 Sep 14.
4
Environmental sensing mechanisms in Bordetella.
Adv Microb Physiol. 2001;44:141-81. doi: 10.1016/s0065-2911(01)44013-6.
7
Bordetella biofilms: a lifestyle leading to persistent infections.
Pathog Dis. 2016 Feb;74(1):ftv108. doi: 10.1093/femspd/ftv108. Epub 2015 Nov 19.
10
Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.
Vaccine. 2012 Aug 31;30(40):5864-70. doi: 10.1016/j.vaccine.2012.07.005. Epub 2012 Jul 17.

引用本文的文献

2
Nanomaterial Adjuvants for Veterinary Vaccines: Mechanisms and Applications.
Research (Wash D C). 2025 Jul 8;8:0761. doi: 10.34133/research.0761. eCollection 2025.
3
Molecular and serological incidences of in pet dogs with urinary infections.
Open Vet J. 2025 Mar;15(3):1397-1406. doi: 10.5455/OVJ.2025.v15.i3.31. Epub 2025 Mar 31.
5
Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management.
Infect Chemother. 2025 Mar;57(1):13-30. doi: 10.3947/ic.2024.0117.
6
Effects of bacteriophages on gut microbiome functionality.
Gut Microbes. 2025 Dec;17(1):2481178. doi: 10.1080/19490976.2025.2481178. Epub 2025 Mar 31.
7
Monitoring of Pathogens Carried by Imported Flies and Cockroaches at Shenzhen Ports.
Trop Med Infect Dis. 2025 Feb 17;10(2):57. doi: 10.3390/tropicalmed10020057.
8
The virulence regulator is required for nutrient-induced filamentation in .
bioRxiv. 2025 Jan 19:2025.01.19.633786. doi: 10.1101/2025.01.19.633786.
9
MASP1 modulation as a novel therapeutic target in severe pediatric pertussis: insights from a multi-omics approach.
Infect Immun. 2025 Feb 18;93(2):e0027124. doi: 10.1128/iai.00271-24. Epub 2025 Jan 22.
10
Case report: First report of and coinfection in an immunocompromised patient.
Front Med (Lausanne). 2024 Oct 22;11:1470567. doi: 10.3389/fmed.2024.1470567. eCollection 2024.

本文引用的文献

1
Case report: : A rare pathogen causing infective endocarditis associated glomerulonephritis.
Front Pediatr. 2023 Jan 16;10:1093300. doi: 10.3389/fped.2022.1093300. eCollection 2022.
2
Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection.
Emerg Microbes Infect. 2023 Dec;12(1):e2174782. doi: 10.1080/22221751.2023.2174782.
5
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients.
Expert Rev Vaccines. 2023 Jan-Dec;22(1):104-117. doi: 10.1080/14760584.2023.2161519. Epub 2022 Dec 26.
6
Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia.
J Glob Antimicrob Resist. 2022 Dec;31:263-269. doi: 10.1016/j.jgar.2022.10.007. Epub 2022 Oct 18.
7
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Co-Infection in a Stem Cell Transplant Patient.
Antibiotics (Basel). 2022 Sep 5;11(9):1200. doi: 10.3390/antibiotics11091200.
8
empyema in patient with chronic alcohol use disorder.
Respir Med Case Rep. 2022 Jul 30;39:101712. doi: 10.1016/j.rmcr.2022.101712. eCollection 2022.
9
Missed pertussis diagnosis during co-infection with Bordetella holmesii.
Eur J Clin Microbiol Infect Dis. 2022 Oct;41(10):1227-1235. doi: 10.1007/s10096-022-04488-3. Epub 2022 Sep 1.
10
Looking beyond Pertussis in Prolonged Cough Illness of Young Children.
Vaccines (Basel). 2022 Jul 27;10(8):1191. doi: 10.3390/vaccines10081191.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验